CLNN furnishes Sep 30, 2025 cash snapshot and ATM proceeds in 8-K

Rhea-AI Filing Summary

Clene Inc. (CLNN) furnished an updated corporate presentation that includes preliminary unaudited figures for its cash and cash equivalents as of September 30, 2025, and the gross proceeds raised under its at-the-market equity distribution agreement from after September 30, 2025 through October 14, 2025. The presentation is attached as Exhibit 99.1.

The company notes these figures were prepared by management and remain subject to completion of financial closing procedures and potential audit adjustments. The materials are furnished under Items 2.02 and 7.01 and are not deemed “filed” for purposes of Section 18 of the Exchange Act, which means they are not subject to its liability provisions or automatically incorporated by reference into other filings.

8-K Event Classification

4 items: 2.02, 7.01, 7.02, 9.01

4 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 7.02 Item 7.02

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001822791 0001822791 2025-10-14 2025-10-14 0001822791 clnn:CommonStock00001ParValueCustomMember 2025-10-14 2025-10-14 0001822791 clnn:WarrantsToAcquireOnefortiethOfOneShareOfCommonStockFor23000PerShareCustomMember 2025-10-14 2025-10-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 14, 2025

CLENE INC.

(Exact name of registrant as specified in its charter)

Delaware	001-39834	85-2828339
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification No.)
6550 South Millrock Drive, Suite G50 Salt Lake City, Utah		84121
(Address of principal executive offices)		(Zip Code)

(801) 676-9695

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value		CLNN		The Nasdaq Capital Market
Warrants, to acquire one-fortieth of one share of Common Stock for $230.00 per share		CLNNW		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On October 14, 2025, Clene Inc. (“the Company”) released an updated corporate presentation (the “Corporate Presentation”) on its website, invest.clene.com, containing the Company’s preliminary unaudited (i) balance of cash and cash equivalents as of September 30, 2025 and (ii) gross proceeds raised from the Company’s equity distribution agreement (the “ATM Agreement”) subsequent to September 30, 2025 through October 14, 2025 (together, the “Financial Information”). The Corporate Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The Financial Information is based on preliminary unaudited information available to the Company and has been prepared by and is the responsibility of management. The Company’s financial closing procedures for the three and nine months ended September 30, 2025 are not yet complete and, as a result, actual results may vary from the preliminary unaudited results presented herein due to the completion of the Company’s financial closing procedures audit procedures. The preliminary Financial Information has not been audited or reviewed by the Company’s independent registered public accounting firm and should not be viewed as a substitute for the Company’s full financial statements. It is possible that the Company or its independent registered public accounting firm may identify necessary adjustments to the preliminary unaudited Financial Information and those changes could be material. Accordingly, you should not place undue reliance on this preliminary unaudited data.

The information furnished in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933 (the “Securities Act”), as amended, regardless of any general incorporation language in any such filings, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01 Regulation FD Disclosure.

The information set forth in Item 2.02 of this Current Report on Form 8-K is incorporated into this Item 7.01 by reference.

The information furnished in this Item 7.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act regardless of any general incorporation language in any such filings, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Exhibit Description
99.1		Corporate Presentation.
104		Cover Page Interactive Data File (formatted as Inline XBRL).

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	CLENE INC.
Date: October 14, 2025	By:	/s/ Robert Etherington
		Robert Etherington
		President and Chief Executive Officer

2

FAQ

What did Clene (CLNN) announce in this 8-K?

Clene furnished a corporate presentation with preliminary unaudited cash as of September 30, 2025 and ATM gross proceeds through October 14, 2025.

Where can I find the disclosed information for CLNN?

It is included in the Corporate Presentation furnished as Exhibit 99.1.

Is the financial information final and audited?

No. It is preliminary unaudited and subject to change upon completion of closing procedures and potential audit adjustments.

Are the materials considered 'filed' under the Exchange Act?

No. The information is furnished, not filed, and is not subject to Section 18 liabilities nor automatically incorporated by reference.

Which 8-K items apply to this CLNN disclosure?

The information is provided under Item 2.02 (Results of Operations and Financial Condition) and incorporated into Item 7.01 (Reg FD).

What period do the ATM proceeds cover for CLNN?

Gross proceeds under the ATM cover activity from after September 30, 2025 through October 14, 2025.